DELIVERY ORDER
Active75N91026F00023
Department of Health and Human Services › National Institutes of Health › NIH NCI
$1.6M
obligated · signed 1 month ago
FFRDC DRUG PRODUCT FORMULATION, MANUFACTURE, AND STABILITY STUDIES OF BETHANECHOL CHLORIDE FOR PHASE I CLINICAL TRIALS
Performance timeline
Start
Sep 21, 2026
End
Sep 20, 2031
with all options
Loading status
Estimated start: Sep 20, 2030
LEIDOS BIOMEDICAL RESEARCH INC
Contract 75N91026F00023
UEI
HV8BH9BPG8Y9
Parent Company
LEIDOS HOLDINGS, INC.
Capabilities & Certifications
Headquarters Location
Congressional District: 06
Current Obligation
$1,644,574
Base + Exercised Options
$1,644,574
Total Ceiling Value
$1,644,574
Contract Type
COST PLUS FIXED FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Place of Performance
Congressional District: 06
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NIH NCI
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NCATS
Office
Contract Vehicle
75N91019D00024
IDCDepartment of Health and Human Services
Award type: SINGLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.